Drugs of today (Barcelona, Spain : 1998)

Keyphrases

Publications

volume 59, number 1, 2023

Sarah A Holstein
Ciltacabtagene autoleucel for the treatment of multiple myeloma. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Xing Liu, Gao-Chuan Fang, Hao Lu, Zhen-Duo Shi, Zhe-Sheng Chen, Cong-Hui Han
Lutetium Lu 177 vipivotide tetraxetan for prostate cancer. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Ana Mendez
The 2022 TOPRA Annual Symposium - Medical Device and IVD Symposium (October 17-19, 2022 - Vienna, Austria). Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Maciej Krzakowski, Dariusz Mirosław Kowalski
Savolitinib for non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)

volume 59, number 2, 2023

Martina Messina, Paul Gissen
Atidarsagene autotemcel for metachromatic leukodystrophy. Drugs of today (Barcelona, Spain : 1998) 59 (2) (2023)
Rusi Chen, Luca Ielasi, Alma di Carlo, Francesco Tovoli
Donafenib in hepatocellular carcinoma. Drugs of today (Barcelona, Spain : 1998) 59 (2) (2023)
Xuan-Yu Chen, Yi-Dong Li, Yuhao Xie, Lu-Qi Cao, Charles R Ashby, Hongbing Zhao, Zhe-Sheng Chen
Nivolumab and relatlimab for the treatment of melanoma. Drugs of today (Barcelona, Spain : 1998) 59 (2) (2023)
Cyriac Manjaly, Jeremy Martinez, John Barbieri, Arash Mostaghimi
Clascoterone for treatment of acne. Drugs of today (Barcelona, Spain : 1998) 59 (2) (2023)
Michael F Loncharich, Ian Robertson
Anifrolumab in systemic lupus erythematosus. Drugs of today (Barcelona, Spain : 1998) 59 (2) (2023)

volume 59, number 3, 2023

Mandy Sakamoto, Antonio Jimeno
Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Federica Pilo, Emanuele Angelucci
Mitapivat for sickle cell disease and thalassemia. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Theodora Simopoulou, Sotirios G Tsiogkas, Efterpi Zafiriou, Dimitrios Petros Bogdanos
Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Zhijian Wang, Yuhao Xie, Jing-Quan Wang, Yuanhui Cheng, Joshua Fleishman, Zhe-Sheng Chen, Yun Chen
Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Kveta Kroupova, Vladimir Palicka, Jan Rosa
Monoclonal antibodies for treatment of osteoporosis. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Kveta Kroupova, Vladimir Palicka, Jan Rosa
Monoclonal antibodies for treatment of osteoporosis. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Giulia Coco, Giulia Piccotti, Vito Romano, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso, Marco Pellegrini, Alice Bruscolini, Marco Marenco, Giuseppe Giannaccare
Cenegermin for the treatment of dry eye disease. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Matthew W McCarthy
Anakinra as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Matthew W McCarthy
Anakinra as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Giulia Coco, Giulia Piccotti, Vito Romano, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso, Marco Pellegrini, Alice Bruscolini, Marco Marenco, Giuseppe Giannaccare
Cenegermin for the treatment of dry eye disease. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)

volume 58, number 12, 2023

John D Zeuli, Christina G Rivera, Bradley L Smith, Ashley Otto, Zelalem Temesgen
Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
Dong-Hua Yang, Qisi Lu, Zhaohui Zhu, Guanghao Huang, Katherine Young
Pacritinib for myelofibrosis in adults with thrombocytopenia. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
Dong-Hua Yang, Qisi Lu, Zhaohui Zhu, Guanghao Huang, Katherine Young
Pacritinib for myelofibrosis in adults with thrombocytopenia. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
John D Zeuli, Christina G Rivera, Bradley L Smith, Ashley Otto, Zelalem Temesgen
Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
Santi Nolasco, Corrado Pelaia, Giulia Scioscia, Raffaele Campisi, Claudia Crimi
Tezepelumab for asthma. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
Ioan-Alexandru Chirap-Mitulschi, Constantin Ghimus, Andreea Raluca Chirap-Mitulschi, Sabina Antonela Antoniu, Raluca Dragomir
COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issues. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)
Santi Nolasco, Corrado Pelaia, Giulia Scioscia, Raffaele Campisi, Claudia Crimi
Tezepelumab for asthma. Drugs of today (Barcelona, Spain : 1998) 58 (12) (2023)

volume 58, number 4, 2022

Jack D Sobel
Ibrexafungerp for the treatment of vulvovaginal candidiasis. Drugs of today (Barcelona, Spain : 1998) 58 (4) (2022)
Angelina Labib, Ashley Vander Does, Gil Yosipovitch
Nemolizumab for atopic dermatitis. Drugs of today (Barcelona, Spain : 1998) 58 (4) (2022)

volume 58, number 5, 2022

Matthew W McCarthy
Fluticasone propionate as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998) 58 (5) (2022)
Bander Balkhi
Efficacy, safety and cost of gene therapy medicinal products in the U.S. and Europe. Drugs of today (Barcelona, Spain : 1998) 58 (5) (2022)
Monia Tumminello
Drug Information Association (DIA) Europe - 34 th Annual Meeting (March 29-31, 2022 - Brussels, Belgium/Virtual). Drugs of today (Barcelona, Spain : 1998) 58 (5) (2022)
Xin Song, Ruyi Li, Hongwei Wang, Peng Song, Wenjing Guo, Zhe-Sheng Chen
Tisotumab vedotin for the treatment of cervical carcinoma. Drugs of today (Barcelona, Spain : 1998) 58 (5) (2022)
Breanna Taylor, Jaimie Cohen, Jennifer Tejeda, Trent Peng Wang
Belumosudil for chronic graft-versus-host disease. Drugs of today (Barcelona, Spain : 1998) 58 (5) (2022)

volume 58, number 6, 2022

Maria Alexandra Rodrigues, Egídio Freitas, Tiago Torres
Bimekizumab for psoriasis. Drugs of today (Barcelona, Spain : 1998) 58 (6) (2022)
Anagha Deshpande, Yucai Wang, Javier Munoz, Preetesh Jain
Brexucabtagene autoleucel: a breakthrough in the treatment of mantle cell lymphoma. Drugs of today (Barcelona, Spain : 1998) 58 (6) (2022)
Anna Skrzypczyk-Ostaszewicz
Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer. Drugs of today (Barcelona, Spain : 1998) 58 (6) (2022)
Congying Gao, Xiangyu Ma, Zifan Zhang, Qisi Lu, Charles R Ashby, Liuya Wei, Zhe-Sheng Chen
Asparaginase Erwinia chrysanthemi for acute lymphoblastic leukemia and lymphoblastic lymphoma. Drugs of today (Barcelona, Spain : 1998) 58 (6) (2022)
X X Author
Title. Drugs of today (Barcelona, Spain : 1998) 58 (6) (2022)

volume 58, number 7, 2022

Bela G Santani, Brian W LeBlanc, Ritesh P Thakare
Molnupiravir for the treatment of COVID-19. Drugs of today (Barcelona, Spain : 1998) 58 (7) (2022)
Saeed Sadeghi
Infigratinib for cholangiocarcinoma. Drugs of today (Barcelona, Spain : 1998) 58 (7) (2022)
Elisabetta K Antonelli, Rachele Del Sordo, Olivia Morelli, Vincenzo Villanacci, Gabrio Bassotti
Update on ozanimod for ulcerative colitis. Drugs of today (Barcelona, Spain : 1998) 58 (7) (2022)
Grace Kaul, Arunava Dasgupta, Sidharth Chopra
Contezolid in complicated skin and soft tissue infection. Drugs of today (Barcelona, Spain : 1998) 58 (7) (2022)

volume 58, number 8, 2022

Yuhao Xie, Qisi Lu, Jing-Quan Wang, Letao Bo, Charles R Ashby, Zhe-Sheng Chen
Amivantamab: a monoclonal EGFR-MET bispecific antibody for EGFR exon 20 insertion in non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 58 (8) (2022)
Kate Bedrin, Jessica Ailani
Atogepant for migraine. Drugs of today (Barcelona, Spain : 1998) 58 (8) (2022)
Omar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, Agne Paner, Alessandra Larocca, Paula Rodríguez-Otero, Xavier Leleu, Paul G Richardson
Melphalan flufenamide for relapsed/refractory multiple myeloma. Drugs of today (Barcelona, Spain : 1998) 58 (8) (2022)
Maddalena Napolitano, Luigi Fornaro, Luca Potestio, Gabriella Fabbrocini, Cataldo Patruno
Abrocitinib in atopic dermatitis: review of the current literature and clinical trials. Drugs of today (Barcelona, Spain : 1998) 58 (8) (2022)

volume 58, number 9, 2022

David M Paton
Efficacy of vosoritide in the treatment of achondroplasia. Drugs of today (Barcelona, Spain : 1998) 58 (9) (2022)
Jessica Huston, Hannah Schaffner, Logan Langley, Blake Skrable, Andrea Ashchi, Jason Berner, Ashwini Gore, Mae Sheikh-Ali, David Sutton, Rebecca Goldfaden
Imeglimin in type 2 diabetes. Drugs of today (Barcelona, Spain : 1998) 58 (9) (2022)
Monia Tumminello
Medicines for Europe - 16th Legal Affairs Conference (June 29-July 1, 2022 - Barcelona, Spain). Drugs of today (Barcelona, Spain : 1998) 58 (9) (2022)
Lucio Manenti, Paride Fenaroli
Difelikefalin for pruritus associated with renal disease. Drugs of today (Barcelona, Spain : 1998) 58 (9) (2022)